25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Accelerate Diagnostics Inc
Buy, Hold or Sell?

Let's analyze Accelerate Diagnostics Inc together

I guess you are interested in Accelerate Diagnostics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Accelerate Diagnostics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Accelerate Diagnostics Inc

I send you an email if I find something interesting about Accelerate Diagnostics Inc.

1. Quick Overview

1.1. Quick analysis of Accelerate Diagnostics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Accelerate Diagnostics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.06
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$-1.94
Expected worth in 1 year
$-2.47
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.48
Return On Investment
-40.4%

For what price can you sell your share?

Current Price per Share
$1.18
Expected price per share
$1.01 - $1.4
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Accelerate Diagnostics Inc (5 min.)




Live pricePrice per Share (EOD)
$1.18
Intrinsic Value Per Share
$-12.71 - $8.50
Total Value Per Share
$-14.65 - $6.57

2.2. Growth of Accelerate Diagnostics Inc (5 min.)




Is Accelerate Diagnostics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$48.4m-$33.6m$1.4m4.4%

How much money is Accelerate Diagnostics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$13.3m-$14.4m$1m8.2%
Net Profit Margin-450.2%-499.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Accelerate Diagnostics Inc (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#309 / 311

Most Revenue
#223 / 311

Most Profit
#258 / 311

Most Efficient
#270 / 311
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Accelerate Diagnostics Inc?

Welcome investor! Accelerate Diagnostics Inc's management wants to use your money to grow the business. In return you get a share of Accelerate Diagnostics Inc.

First you should know what it really means to hold a share of Accelerate Diagnostics Inc. And how you can make/lose money.

Speculation

The Price per Share of Accelerate Diagnostics Inc is $1.18. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Accelerate Diagnostics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Accelerate Diagnostics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-1.94. Based on the TTM, the Book Value Change Per Share is $-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Accelerate Diagnostics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.58-49.5%-0.53-45.2%-0.64-54.6%-0.68-58.0%-0.68-57.4%
Usd Book Value Change Per Share-0.54-46.0%-0.13-11.4%-0.25-21.3%-0.12-9.9%-0.12-10.2%
Usd Dividend Per Share0.000.0%0.021.3%0.000.0%0.000.4%0.000.2%
Usd Total Gains Per Share-0.54-46.0%-0.12-10.1%-0.25-21.3%-0.11-9.5%-0.12-10.0%
Usd Price Per Share1.71-1.95-1.99-5.29-13.25-
Price to Earnings Ratio-0.73--0.92-9.72-0.26--4.16-
Price-to-Total Gains Ratio-3.15--1.17-91.09-8.31--16.06-
Price to Book Ratio-0.88--1.91--1.47--5.85-1.87-
Price-to-Total Gains Ratio-3.15--1.17-91.09-8.31--16.06-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.18
Number of shares847
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.00
Usd Book Value Change Per Share-0.13-0.12
Usd Total Gains Per Share-0.12-0.11
Gains per Quarter (847 shares)-100.93-95.38
Gains per Year (847 shares)-403.72-381.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
151-455-41416-397-392
2102-910-81831-794-774
3153-1364-122247-1191-1156
4204-1819-162662-1588-1538
5256-2274-203078-1985-1920
6307-2729-243493-2382-2302
7358-3184-2838109-2779-2684
8409-3639-3242124-3176-3066
9460-4093-3646140-3574-3448
10511-4548-4050155-3971-3830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.039.00.02.5%20.096.00.017.2%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%6.014.00.030.0%8.032.00.020.0%30.072.014.025.9%
Dividend per Share1.00.03.025.0%4.00.08.033.3%4.00.016.020.0%4.00.036.010.0%8.00.0108.06.9%
Total Gains per Share1.03.00.025.0%5.07.00.041.7%6.014.00.030.0%8.032.00.020.0%32.071.013.027.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Accelerate Diagnostics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.543-0.134-75%-0.252-54%-0.117-78%-0.121-78%
Book Value Per Share---1.936-1.288-33%-1.344-31%-1.563-19%0.832-333%
Current Ratio--1.5031.578-5%0.779+93%6.716-78%14.305-89%
Debt To Asset Ratio--2.5002.125+18%1.692+48%1.667+50%0.975+156%
Debt To Equity Ratio----0%-0%-0%0.712-100%
Dividend Per Share---0.015-100%-0%0.005-100%0.002-100%
Enterprise Value---17059102.0002103300.500-911%-2780772.300-84%72161608.453-124%335689064.177-105%
Eps---0.585-0.534-9%-0.644+10%-0.685+17%-0.678+16%
Ev To Ebitda Ratio--0.495-0.037+108%0.074+570%-1.131+329%-5.756+1263%
Ev To Sales Ratio---1.4340.161-988%-0.485-66%6.454-122%1262.555-100%
Free Cash Flow Per Share---0.103-0.269+162%-0.429+318%-0.446+334%-0.501+387%
Free Cash Flow To Equity Per Share--0.4880.008+6378%-0.342+170%-0.199+141%-0.049+110%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8.502--------
Intrinsic Value_10Y_min---12.712--------
Intrinsic Value_1Y_max---1.267--------
Intrinsic Value_1Y_min---1.892--------
Intrinsic Value_3Y_max---2.192--------
Intrinsic Value_3Y_min---5.183--------
Intrinsic Value_5Y_max---1.170--------
Intrinsic Value_5Y_min---7.899--------
Market Cap29551684.000-45%42824898.00048772800.500-12%49874727.700-14%132442508.453-68%331817014.177-87%
Net Profit Margin---4.921-4.502-9%-4.995+2%-5.753+17%-113.158+2200%
Operating Margin---3.192-3.418+7%-4.764+49%-5.064+59%-112.561+3426%
Operating Ratio--3.8974.213-8%5.806-33%6.056-36%213.744-98%
Pb Ratio-0.610+31%-0.883-1.905+116%-1.470+66%-5.849+562%1.867-147%
Pe Ratio-0.505+31%-0.731-0.922+26%9.717-108%0.260-381%-4.159+469%
Price Per Share1.180-45%1.7101.948-12%1.992-14%5.288-68%13.249-87%
Price To Free Cash Flow Ratio-2.868+31%-4.156-2.233-46%-1.311-68%-3.012-28%-6.728+62%
Price To Total Gains Ratio-2.174+31%-3.150-1.170-63%91.093-103%8.314-138%-16.063+410%
Quick Ratio--1.3231.224+8%0.680+95%8.365-84%19.673-93%
Return On Assets---0.453-0.459+1%-0.269-41%-0.269-41%-0.206-54%
Return On Equity----0%-0%-0%-0.1650%
Total Gains Per Share---0.543-0.119-78%-0.252-54%-0.113-79%-0.118-78%
Usd Book Value---48481000.000-32259000.000-33%-33671250.000-31%-39149050.000-19%20830450.000-333%
Usd Book Value Change Per Share---0.543-0.134-75%-0.252-54%-0.117-78%-0.121-78%
Usd Book Value Per Share---1.936-1.288-33%-1.344-31%-1.563-19%0.832-333%
Usd Dividend Per Share---0.015-100%-0%0.005-100%0.002-100%
Usd Enterprise Value---17059102.0002103300.500-911%-2780772.300-84%72161608.453-124%335689064.177-105%
Usd Eps---0.585-0.534-9%-0.644+10%-0.685+17%-0.678+16%
Usd Free Cash Flow---2576000.000-6747750.000+162%-10756250.000+318%-11168450.000+334%-12546950.000+387%
Usd Free Cash Flow Per Share---0.103-0.269+162%-0.429+318%-0.446+334%-0.501+387%
Usd Free Cash Flow To Equity Per Share--0.4880.008+6378%-0.342+170%-0.199+141%-0.049+110%
Usd Market Cap29551684.000-45%42824898.00048772800.500-12%49874727.700-14%132442508.453-68%331817014.177-87%
Usd Price Per Share1.180-45%1.7101.948-12%1.992-14%5.288-68%13.249-87%
Usd Profit---14639000.000-13364250.000-9%-14454000.000-1%-16762500.000+15%-16780250.000+15%
Usd Revenue--2975000.0002970500.000+0%3001000.000-1%3004000.000-1%1905625.000+56%
Usd Total Gains Per Share---0.543-0.119-78%-0.252-54%-0.113-79%-0.118-78%
 EOD+2 -6MRQTTM+13 -24YOY+16 -195Y+15 -2210Y+17 -22

3.3 Fundamental Score

Let's check the fundamental score of Accelerate Diagnostics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.505
Price to Book Ratio (EOD)Between0-1-0.610
Net Profit Margin (MRQ)Greater than0-4.921
Operating Margin (MRQ)Greater than0-3.192
Quick Ratio (MRQ)Greater than11.323
Current Ratio (MRQ)Greater than11.503
Debt to Asset Ratio (MRQ)Less than12.500
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.453
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Accelerate Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.607
Ma 20Greater thanMa 501.234
Ma 50Greater thanMa 1001.248
Ma 100Greater thanMa 2001.526
OpenGreater thanClose1.220
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Accelerate Diagnostics Inc

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Fundamental data was last updated by Penke on 2025-02-06 12:02:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Accelerate Diagnostics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • A Net Profit Margin of -492.1% means that $-4.92 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Accelerate Diagnostics Inc:

  • The MRQ is -492.1%. The company is making a huge loss. -2
  • The TTM is -450.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-492.1%TTM-450.2%-41.9%
TTM-450.2%YOY-499.5%+49.3%
TTM-450.2%5Y-575.3%+125.2%
5Y-575.3%10Y-11,315.8%+10,740.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-492.1%-6.4%-485.7%
TTM-450.2%-13.7%-436.5%
YOY-499.5%-14.5%-485.0%
5Y-575.3%-14.8%-560.5%
10Y-11,315.8%-14.5%-11,301.3%
4.3.1.2. Return on Assets

Shows how efficient Accelerate Diagnostics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • -45.3% Return on Assets means that Accelerate Diagnostics Inc generated $-0.45 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Accelerate Diagnostics Inc:

  • The MRQ is -45.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -45.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-45.3%TTM-45.9%+0.6%
TTM-45.9%YOY-26.9%-19.0%
TTM-45.9%5Y-26.9%-19.1%
5Y-26.9%10Y-20.6%-6.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.3%-2.3%-43.0%
TTM-45.9%-3.0%-42.9%
YOY-26.9%-3.9%-23.0%
5Y-26.9%-2.8%-24.1%
10Y-20.6%-3.6%-17.0%
4.3.1.3. Return on Equity

Shows how efficient Accelerate Diagnostics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • 0.0% Return on Equity means Accelerate Diagnostics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Accelerate Diagnostics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-16.5%+16.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--2.9%+2.9%
TTM--3.9%+3.9%
YOY--4.0%+4.0%
5Y--4.0%+4.0%
10Y-16.5%-5.0%-11.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Accelerate Diagnostics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Accelerate Diagnostics Inc is operating .

  • Measures how much profit Accelerate Diagnostics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • An Operating Margin of -319.2% means the company generated $-3.19  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Accelerate Diagnostics Inc:

  • The MRQ is -319.2%. The company is operating very inefficient. -2
  • The TTM is -341.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-319.2%TTM-341.8%+22.7%
TTM-341.8%YOY-476.4%+134.5%
TTM-341.8%5Y-506.4%+164.6%
5Y-506.4%10Y-11,256.1%+10,749.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-319.2%-13.5%-305.7%
TTM-341.8%-21.4%-320.4%
YOY-476.4%-11.8%-464.6%
5Y-506.4%-16.3%-490.1%
10Y-11,256.1%-16.5%-11,239.6%
4.3.2.2. Operating Ratio

Measures how efficient Accelerate Diagnostics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 3.90 means that the operating costs are $3.90 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 3.897. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.213. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.897TTM4.213-0.317
TTM4.213YOY5.806-1.592
TTM4.2135Y6.056-1.842
5Y6.05610Y213.744-207.688
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8971.305+2.592
TTM4.2131.297+2.916
YOY5.8061.321+4.485
5Y6.0561.360+4.696
10Y213.7441.303+212.441
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Accelerate Diagnostics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Accelerate Diagnostics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.50 means the company has $1.50 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 1.503. The company is able to pay all its short-term debts. +1
  • The TTM is 1.578. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.503TTM1.578-0.075
TTM1.578YOY0.779+0.799
TTM1.5785Y6.716-5.138
5Y6.71610Y14.305-7.588
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5032.596-1.093
TTM1.5782.712-1.134
YOY0.7792.894-2.115
5Y6.7163.515+3.201
10Y14.3053.470+10.835
4.4.3.2. Quick Ratio

Measures if Accelerate Diagnostics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • A Quick Ratio of 1.32 means the company can pay off $1.32 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 1.323. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.224. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.323TTM1.224+0.099
TTM1.224YOY0.680+0.545
TTM1.2245Y8.365-7.140
5Y8.36510Y19.673-11.308
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3231.488-0.165
TTM1.2241.572-0.348
YOY0.6801.875-1.195
5Y8.3652.415+5.950
10Y19.6732.550+17.123
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Accelerate Diagnostics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Accelerate Diagnostics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Accelerate Diagnostics Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 2.50 means that Accelerate Diagnostics Inc assets are financed with 250.0% credit (debt) and the remaining percentage (100% - 250.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 2.500. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.125. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.500TTM2.125+0.375
TTM2.125YOY1.692+0.433
TTM2.1255Y1.667+0.457
5Y1.66710Y0.975+0.692
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5000.403+2.097
TTM2.1250.406+1.719
YOY1.6920.370+1.322
5Y1.6670.429+1.238
10Y0.9750.449+0.526
4.5.4.2. Debt to Equity Ratio

Measures if Accelerate Diagnostics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.712-0.712
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.580-0.580
TTM-0.623-0.623
YOY-0.551-0.551
5Y-0.641-0.641
10Y0.7120.717-0.005
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Accelerate Diagnostics Inc generates.

  • Above 15 is considered overpriced but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • A PE ratio of -0.73 means the investor is paying $-0.73 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Accelerate Diagnostics Inc:

  • The EOD is -0.505. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.731. Based on the earnings, the company is expensive. -2
  • The TTM is -0.922. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.505MRQ-0.731+0.227
MRQ-0.731TTM-0.922+0.190
TTM-0.922YOY9.717-10.638
TTM-0.9225Y0.260-1.182
5Y0.26010Y-4.159+4.420
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.505-1.475+0.970
MRQ-0.731-1.755+1.024
TTM-0.922-2.155+1.233
YOY9.717-3.044+12.761
5Y0.260-2.530+2.790
10Y-4.159-2.241-1.918
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Accelerate Diagnostics Inc:

  • The EOD is -2.868. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.156. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.233. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.868MRQ-4.156+1.288
MRQ-4.156TTM-2.233-1.923
TTM-2.233YOY-1.311-0.923
TTM-2.2335Y-3.012+0.778
5Y-3.01210Y-6.728+3.716
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.868-1.746-1.122
MRQ-4.156-1.987-2.169
TTM-2.233-2.2330.000
YOY-1.311-5.598+4.287
5Y-3.012-3.825+0.813
10Y-6.728-4.975-1.753
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Accelerate Diagnostics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -0.88 means the investor is paying $-0.88 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Accelerate Diagnostics Inc:

  • The EOD is -0.610. Based on the equity, the company is expensive. -2
  • The MRQ is -0.883. Based on the equity, the company is expensive. -2
  • The TTM is -1.905. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.610MRQ-0.883+0.274
MRQ-0.883TTM-1.905+1.022
TTM-1.905YOY-1.470-0.435
TTM-1.9055Y-5.849+3.943
5Y-5.84910Y1.867-7.715
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.6102.131-2.741
MRQ-0.8832.268-3.151
TTM-1.9052.385-4.290
YOY-1.4703.050-4.520
5Y-5.8494.281-10.130
10Y1.8674.589-2.722
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Accelerate Diagnostics Inc.

4.8.1. Institutions holding Accelerate Diagnostics Inc

Institutions are holding 17.452% of the shares of Accelerate Diagnostics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Armistice Capital, LLC8.38930.0575210100049300030.6592
2024-12-31Hovey Youngman Associates Inc4.00730.14151003581-241774-19.4141
2024-09-30Vanguard Group Inc1.8888047303415800050.1533
2024-09-30Geode Capital Management, LLC0.50690126955-7782-5.7757
2024-09-30Spears Abacus Advisors LLC0.45730.003911452300
2024-12-31Tci Wealth Advisors Inc0.2220.00565558600
2024-09-30BlackRock Inc0.20305084200
2024-09-30Renaissance Technologies Corp0.1640.000141078410780
2024-09-30Cladis Investment Advisory LLC0.15850.04739700-39700-50
2024-09-30Belpointe Asset Management LLC0.13550.003533941-23-0.0677
2024-09-30Northern Trust Corp0.121030311-4376-12.6157
2024-09-30State Street Corp0.081502041500
2024-12-31Ironwood Wealth Management, LLC0.08110.00512031300
2024-09-30Y-Intercept (Hong Kong) Ltd0.07930.002119866198660
2024-09-30Millennium Management LLC0.0679017012-2572-13.1332
2024-09-30Tudor Investment Corp Et AL0.05640.00011411400
2024-09-30Tejara Capital Ltd0.05410.011113556-58-0.426
2024-09-30Citadel Advisors Llc0.05012512125120
2024-09-30OCCUDO QUANTITATIVE STRATEGIES LP0.04480.023811225112250
2024-12-31Stratos Wealth Partners, LTD0.04240.000210628106280
Total 16.81110.30154210192+450024+10.7%

4.9.2. Funds holding Accelerate Diagnostics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31Vanguard Total Stock Mkt Idx Inv1.5232038145600
2024-12-31Vanguard Institutional Extnd Mkt Idx Tr0.38070.00019533300
2024-12-31Fidelity Extended Market Index0.2950.000273878-595-0.7989
2024-12-31Fidelity Series Total Market Index0.071201782600
2024-12-31Fidelity Total Market Index0.060201506400
2024-12-31Extended Equity Market Fund K0.04580.000111460-158-1.36
2024-12-31Fidelity Nasdaq Composite Index0.04360.000110919485079.9143
2024-12-31Thompson MidCap0.04150.02271039000
2024-12-31Spartan Total Market Index Pool E0.03670918000
2024-12-31NT Ext Equity Mkt Idx Fd - L0.03630.0001909300
2024-12-31Northern Trust Extended Eq Market Idx0.03630.0001909300
2024-12-31Spartan Extended Market Index Pool E0.03520.000288265957.2288
2024-12-31NT Ext Equity Mkt Idx Fd - NL0.02730.0001682900
2024-12-31T. Rowe Price U.S. Equities Tr0.02550.0001639000
2024-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.02160.00015413-89-1.6176
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.00870.0001216721670
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.00870.0001216721670
2024-12-31Extended Equity Market Fund M0.00590.00011489140.9492
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00560.0002140320.1428
2024-12-31Vanguard U.S. Eq Idx £ Acc0.00520130400
Total 2.71420.0244679680+8953+1.3%

5.3. Insider Transactions

Insiders are holding 40.605% of the shares of Accelerate Diagnostics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-12-03John PatienceBUY2000001.57
2024-05-20Larry Michael MertzSELL3610.88
2024-04-17Jack PhillipsSELL267350.78
2024-04-12Jack PhillipsSELL265450.86
2024-04-09David PatienceSELL132960.87
2024-04-09Larry Michael MertzSELL139840.87
2024-04-04Jack PhillipsSELL158870.88
2024-04-04Larry Michael MertzSELL9780.88
2024-02-26David PatienceSELL3500.96
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets32,315
Total Liabilities80,796
Total Stockholder Equity-48,481
 As reported
Total Liabilities 80,796
Total Stockholder Equity+ -48,481
Total Assets = 32,315

Assets

Total Assets32,315
Total Current Assets27,436
Long-term Assets4,879
Total Current Assets
Cash And Cash Equivalents 19,691
Short-term Investments 1,221
Net Receivables 2,027
Inventory 2,978
Other Current Assets 1,519
Total Current Assets  (as reported)27,436
Total Current Assets  (calculated)27,436
+/-0
Long-term Assets
Property Plant Equipment 4,116
Long-term Assets Other 763
Long-term Assets  (as reported)4,879
Long-term Assets  (calculated)4,879
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities18,258
Long-term Liabilities62,538
Total Stockholder Equity-48,481
Total Current Liabilities
Short-term Debt 922
Accounts payable 4,714
Other Current Liabilities 11,951
Total Current Liabilities  (as reported)18,258
Total Current Liabilities  (calculated)17,587
+/- 671
Long-term Liabilities
Long term Debt 58,005
Capital Lease Obligations 969
Long-term Liabilities Other 2,017
Long-term Liabilities  (as reported)62,538
Long-term Liabilities  (calculated)60,991
+/- 1,547
Total Stockholder Equity
Retained Earnings -709,313
Accumulated Other Comprehensive Income -1,057
Other Stockholders Equity 661,889
Total Stockholder Equity (as reported)-48,481
Total Stockholder Equity (calculated)-48,481
+/-0
Other
Capital Stock25
Cash and Short Term Investments 20,912
Common Stock Shares Outstanding 24,915
Current Deferred Revenue671
Liabilities and Stockholders Equity 32,315
Net Debt 39,283
Net Invested Capital 9,524
Net Working Capital 9,178
Property Plant and Equipment Gross 16,105
Short Long Term Debt Total 58,974



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-30
> Total Assets 
0
1,200
1,600
2,300
2,700
8,900
9,200
9,800
9,800
13,042
14,850
13,975
13,975
13,820
14,100
14,073
13,889
14,073
13,127
13,106
13,106
12,073
11,493
10,732
10,732
12,306
14,047
15,024
15,024
14,700
14,130
13,745
13,745
13,024
12,692
12,725
12,725
11,926
11,381
11,008
11,008
9,289
8,564
7,848
7,848
7,025
6,570
6,138
6,138
5,571
5,924
5,827
5,827
5,468
5,382
5,231
5,231
4,489
4,506
6,269
6,418
6,437
6,359
6,359
6,264
6,013
5,679
17,214
17,214
13,300
31,229
29,332
45,933
43,430
41,417
81,804
75,153
69,801
63,337
53,347
44,755
139,324
125,648
110,515
96,632
82,852
74,404
148,257
136,107
125,512
213,115
218,253
200,656
185,265
172,185
158,644
147,278
134,424
119,993
114,815
104,219
93,425
92,668
93,989
81,161
83,047
70,357
58,726
75,847
65,015
51,002
49,878
39,324
31,366
30,722
22,867
32,315
32,31522,86730,72231,36639,32449,87851,00265,01575,84758,72670,35783,04781,16193,98992,66893,425104,219114,815119,993134,424147,278158,644172,185185,265200,656218,253213,115125,512136,107148,25774,40482,85296,632110,515125,648139,32444,75553,34763,33769,80175,15381,80441,41743,43045,93329,33231,22913,30017,21417,2145,6796,0136,2646,3596,3596,4376,4186,2694,5064,4895,2315,2315,3825,4685,8275,8275,9245,5716,1386,1386,5707,0257,8487,8488,5649,28911,00811,00811,38111,92612,72512,72512,69213,02413,74513,74514,13014,70015,02415,02414,04712,30610,73210,73211,49312,07313,10613,10613,12714,07313,88914,07314,10013,82013,97513,97514,85013,0429,8009,8009,2008,9002,7002,3001,6001,2000
   > Total Current Assets 
0
1,000
1,300
2,000
2,300
8,600
8,700
9,000
9,000
11,791
13,348
12,026
12,026
11,402
11,652
11,658
11,554
11,658
11,038
11,123
11,123
10,207
9,931
9,652
9,652
8,881
8,719
9,879
9,879
9,611
9,039
8,773
8,773
8,052
7,712
7,504
7,504
6,731
6,194
6,131
6,131
4,444
3,780
3,084
3,084
2,279
1,883
1,532
1,532
1,009
1,410
1,376
1,376
1,140
1,086
943
943
211
258
751
939
913
863
863
1,423
1,180
868
15,042
15,042
12,800
30,142
28,113
44,634
42,143
39,571
79,668
72,698
67,098
59,664
49,433
40,920
134,151
120,276
105,403
91,681
78,448
70,349
143,273
131,280
120,488
207,135
212,608
192,884
177,640
164,000
150,174
134,395
121,852
106,744
102,508
92,039
81,987
81,811
83,695
71,516
73,331
61,111
48,059
66,272
56,014
42,834
42,239
32,443
24,466
24,133
17,170
27,436
27,43617,17024,13324,46632,44342,23942,83456,01466,27248,05961,11173,33171,51683,69581,81181,98792,039102,508106,744121,852134,395150,174164,000177,640192,884212,608207,135120,488131,280143,27370,34978,44891,681105,403120,276134,15140,92049,43359,66467,09872,69879,66839,57142,14344,63428,11330,14212,80015,04215,0428681,1801,4238638639139397512582119439431,0861,1401,3761,3761,4101,0091,5321,5321,8832,2793,0843,0843,7804,4446,1316,1316,1946,7317,5047,5047,7128,0528,7738,7739,0399,6119,8799,8798,7198,8819,6529,6529,93110,20711,12311,12311,03811,65811,55411,65811,65211,40212,02612,02613,34811,7919,0009,0008,7008,6002,3002,0001,3001,0000
       Cash And Cash Equivalents 
0
900
1,100
1,400
1,700
8,000
7,900
7,900
7,900
9,286
10,283
10,439
10,439
10,167
10,293
10,257
10,559
10,257
10,311
10,360
10,360
10,021
9,798
9,522
9,522
8,693
8,607
8,631
8,631
9,177
8,691
8,712
8,712
7,803
7,511
7,233
7,233
6,424
5,898
5,564
5,564
4,184
3,517
3,004
3,004
2,102
1,801
1,394
1,394
879
1,277
1,233
1,233
987
979
862
862
109
166
283
222
425
372
372
776
513
213
14,263
14,263
12,100
29,257
27,173
33,453
30,029
26,142
65,212
57,851
53,563
47,391
35,231
25,191
120,585
72,033
37,519
28,731
19,244
9,917
62,609
34,431
28,513
126,847
66,810
61,622
66,260
75,309
87,469
92,938
61,014
39,487
47,368
27,029
35,781
42,726
44,580
35,725
39,898
13,654
4,581
38,987
34,905
29,408
29,282
20,162
12,138
14,606
8,588
19,691
19,6918,58814,60612,13820,16229,28229,40834,90538,9874,58113,65439,89835,72544,58042,72635,78127,02947,36839,48761,01492,93887,46975,30966,26061,62266,810126,84728,51334,43162,6099,91719,24428,73137,51972,033120,58525,19135,23147,39153,56357,85165,21226,14230,02933,45327,17329,25712,10014,26314,2632135137763723724252222831661098628629799871,2331,2331,2778791,3941,3941,8012,1023,0043,0043,5174,1845,5645,5645,8986,4247,2337,2337,5117,8038,7128,7128,6919,1778,6318,6318,6078,6939,5229,5229,79810,02110,36010,36010,31110,25710,55910,25710,29310,16710,43910,43910,2839,2867,9007,9007,9008,0001,7001,4001,1009000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,960
11,959
12,420
13,800
14,081
13,115
11,061
13,030
13,840
11,839
44,630
64,919
61,422
58,519
54,029
72,609
86,889
80,648
66,754
130,594
118,982
100,218
75,550
50,349
28,978
47,437
52,525
41,326
50,463
32,488
23,954
24,251
21,299
23,720
36,722
32,191
16,407
10,656
2,457
1,423
989
1,081
1,145
1,158
1,221
1,2211,1581,1451,0819891,4232,45710,65616,40732,19136,72223,72021,29924,25123,95432,48850,46341,32652,52547,43728,97850,34975,550100,218118,982130,59466,75480,64886,88972,60954,02958,51961,42264,91944,63011,83913,84013,03011,06113,11514,08113,80012,42011,95910,960000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
100
200
400
400
300
600
900
900
2,188
2,763
1,415
1,415
1,065
1,132
1,122
688
1,122
300
277
277
92
59
69
69
99
33
1,186
1,186
81
262
6
6
115
75
199
199
190
187
311
311
8
7
11
11
121
17
6
6
11
6
6
6
50
50
0
50
15
20
416
672
417
428
428
596
596
600
751
751
800
794
818
106
24
40
40
89
78
92
143
742
77
77
169
159
34
551
682
1,111
1,946
1,065
1,823
1,440
1,860
1,950
1,911
2,642
3,222
3,143
2,592
2,610
1,550
1,976
2,114
2,269
2,320
2,114
2,935
2,393
2,416
2,427
2,342
2,666
2,622
2,217
2,289
2,027
2,0272,2892,2172,6222,6662,3422,4272,4162,3932,9352,1142,3202,2692,1141,9761,5502,6102,5923,1433,2222,6421,9111,9501,8601,4401,8231,0651,9461,111682551341591697777742143927889404024106818794800751751600596596428428417672416201550050506661166171211111783113111871901991997511566262811,1861,1863399696959922772773001,1226881,1221,1321,0651,4151,4152,7632,1889009006003004004002001000
       Other Current Assets 
0
0
0
200
200
300
200
200
200
317
301
171
171
170
227
279
307
279
427
486
486
91
71
61
61
90
80
62
62
257
86
55
55
65
62
41
7
84
85
228
228
226
231
43
43
27
35
24
24
19
35
39
39
25
38
28
28
50
37
19
11
37
32
21
21
41
25
18
18
6
92
122
115
130
969
616
677
342
647
1,029
1,147
12
1,224
1,232
102
183
468
496
460
468
804
643
494
576
712
805
793
1,165
1,291
1,099
1,517
1,780
1,479
1,498
1,513
1,558
1,594
1,619
1,974
2,025
1,575
2,812
3,638
5,315
2,916
1,912
1,519
1,5191,9122,9165,3153,6382,8121,5752,0251,9741,6191,5941,5581,5131,4981,4791,7801,5171,0991,2911,1657938057125764946438044684604964681831021,2321,224121,1471,0296473426776169691301151229261818254121213237111937502828382539393519242435274343231226228228858474162655555862576262809061617191486486427279307279227170171171301317200200200300200200000
   > Long-term Assets 
0
200
300
300
400
300
500
800
800
1,251
1,502
1,949
1,949
2,418
2,448
2,414
2,335
2,414
2,089
1,983
1,983
1,866
1,562
1,079
1,079
3,425
5,328
5,145
5,145
5,088
5,091
4,972
4,972
4,972
4,980
5,221
5,221
5,195
5,187
0
4,877
4,845
4,784
4,764
4,764
4,745
4,688
4,606
4,606
4,562
4,513
4,451
4,451
4,328
4,296
4,288
4,288
4,279
4,248
5,518
5,479
5,524
5,496
5,496
4,841
4,833
4,811
2,171
2,171
500
1,087
1,218
1,299
1,287
1,846
2,136
2,455
2,703
3,673
3,914
3,835
5,173
5,372
5,112
4,951
4,404
4,055
4,984
4,827
5,024
5,980
5,645
7,772
7,625
8,185
8,470
12,883
12,572
13,249
12,307
12,180
11,438
10,857
10,294
9,645
9,716
9,246
10,667
9,575
9,001
8,168
7,639
6,881
6,900
6,589
5,697
4,879
4,8795,6976,5896,9006,8817,6398,1689,0019,57510,6679,2469,7169,64510,29410,85711,43812,18012,30713,24912,57212,8838,4708,1857,6257,7725,6455,9805,0244,8274,9844,0554,4044,9515,1125,3725,1733,8353,9143,6732,7032,4552,1361,8461,2871,2991,2181,0875002,1712,1714,8114,8334,8415,4965,4965,5245,4795,5184,2484,2794,2884,2884,2964,3284,4514,4514,5134,5624,6064,6064,6884,7454,7644,7644,7844,8454,87705,1875,1955,2215,2214,9804,9724,9724,9725,0915,0885,1455,1455,3283,4251,0791,0791,5621,8661,9831,9832,0892,4142,3352,4142,4482,4181,9491,9491,5021,2518008005003004003003002000
       Property Plant Equipment 
0
100
100
100
100
100
100
200
200
234
249
293
293
288
271
258
241
258
197
180
180
213
162
82
82
70
65
77
77
78
81
142
142
127
204
217
217
201
247
231
231
221
200
180
180
144
125
107
107
61
49
37
37
26
20
15
15
10
7
4
5
5
4
4
4
2
2
4
4
148
777
930
1,039
1,047
1,624
1,933
2,270
2,536
3,508
3,752
3,676
5,016
5,218
4,960
4,802
4,258
3,912
4,844
4,690
4,890
5,851
5,443
7,412
7,303
7,729
7,999
12,400
11,822
12,381
11,573
10,506
9,318
8,832
8,396
7,822
7,899
7,455
8,816
7,952
7,759
7,073
6,514
5,768
5,084
5,379
4,815
4,116
4,1164,8155,3795,0845,7686,5147,0737,7597,9528,8167,4557,8997,8228,3968,8329,31810,50611,57312,38111,82212,4007,9997,7297,3037,4125,4435,8514,8904,6904,8443,9124,2584,8024,9605,2185,0163,6763,7523,5082,5362,2701,9331,6241,0471,0399307771484422444554710151520263737496110710712514418018020022123123124720121721720412714214281787777657082821622131801801972582412582712882932932492342002001001001001001001000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
482
2,799
4,217
4,623
0
0
4,470
4,256
4,205
4,153
4,104
4,071
4,018
3,975
3,929
3,879
3,820
3,761
3,701
3,712
3,652
3,592
3,532
3,472
3,447
3,400
3,371
3,347
3,288
3,246
3,204
3,170
3,120
3,070
3,017
2,968
2,920
2,861
2,823
2,788
1,377
1,394
1,414
1,486
193
193
310
288
260
241
222
203
185
167
165
162
159
157
154
152
149
146
143
140
137
134
129
124
119
114
108
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000001081141191241291341371401431461491521541571591621651671852032222412602883101931931,4861,4141,3941,3772,7882,8232,8612,9202,9683,0173,0703,1203,1703,2043,2463,2883,3473,3713,4003,4473,4723,5323,5923,6523,7123,7013,7613,8203,8793,9293,9754,0184,0714,1044,1534,2054,2564,470004,6234,2172,799482000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
747
745
743
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000007437457470000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
485
485
2,799
537
4,623
4,623
4,517
4,470
4,256
4,256
4,153
4,104
4,071
4,071
3,975
3,929
3,879
3,879
3,761
3,701
3,712
3,712
3,592
3,532
3,472
3,472
3,400
3,371
3,347
3,347
3,288
3,204
3,169
3,120
3,069
3,017
2,967
2,920
2,861
2,824
2,787
2,788
2,691
2,651
681
681
300
310
288
260
241
222
203
185
167
165
162
159
157
154
152
149
146
143
140
137
134
129
124
119
114
108
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000001081141191241291341371401431461491521541571591621651671852032222412602883103006816812,6512,6912,7882,7872,8242,8612,9202,9673,0173,0693,1203,1693,2043,2883,3473,3473,3713,4003,4723,4723,5323,5923,7123,7123,7013,7613,8793,8793,9293,9754,0714,0714,1044,1534,2564,2564,4704,5174,6234,6235372,79948548500000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,272
1,891
1,803
1,690
1,653
1,400
998
1,013
3,355
5,263
5,068
5,086
5,010
5,010
4,830
4,869
4,845
4,776
5,004
5,027
4,994
4,940
4,646
4,660
4,624
4,584
4,584
4,645
4,602
4,562
4,499
4,586
4,501
4,464
4,414
4,381
4,302
4,276
4,273
4,310
4,268
4,241
5,514
5,474
5,520
5,492
4,837
4,862
4,831
4,809
2,168
1,823
0
309
288
260
240
222
203
185
167
165
162
159
157
154
152
149
146
143
140
137
134
129
78
241
208
348
471
483
750
868
734
1,674
5,303
2,025
1,898
1,823
1,817
1,791
1,851
1,623
1,242
0
1,125
1,113
0
0
0
0
00001,1131,12501,2421,6231,8511,7911,8171,8231,8982,0255,3031,6747348687504834713482082417812913413714014314614915215415715916216516718520322224026028830901,8232,1684,8094,8314,8624,8375,4925,5205,4745,5144,2414,2684,3104,2734,2764,3024,3814,4144,4644,5014,5864,4994,5624,6024,6454,5844,5844,6244,6604,6464,9404,9945,0275,0044,7764,8454,8694,8305,0105,0105,0865,0685,2633,3551,0139981,4001,6531,6901,8031,8912,27200000000000000000
> Total Liabilities 
0
200
200
400
500
400
300
600
600
1,522
2,172
1,619
1,619
1,420
1,837
1,837
1,841
1,837
1,725
1,844
1,844
1,361
1,133
1,120
1,120
854
821
1,279
1,279
1,363
911
1,016
1,016
1,093
1,137
988
988
1,014
1,032
1,340
1,340
1,161
1,211
1,109
1,109
1,259
1,275
1,258
1,258
1,480
1,374
1,414
1,414
1,307
1,400
1,337
1,337
1,371
1,412
1,359
1,432
1,474
1,514
1,514
1,449
1,663
1,658
2,378
2,378
1,200
1,136
1,807
939
1,914
2,608
3,100
2,876
3,810
4,515
3,997
4,568
6,306
5,987
5,474
5,449
5,036
5,271
6,223
6,183
6,808
106,640
123,367
123,250
127,890
129,217
132,639
137,058
141,803
142,935
151,805
153,887
156,237
159,032
163,739
120,908
118,118
127,133
120,690
85,644
87,279
89,727
88,541
74,357
51,254
56,502
57,754
80,796
80,79657,75456,50251,25474,35788,54189,72787,27985,644120,690127,133118,118120,908163,739159,032156,237153,887151,805142,935141,803137,058132,639129,217127,890123,250123,367106,6406,8086,1836,2235,2715,0365,4495,4745,9876,3064,5683,9974,5153,8102,8763,1002,6081,9149391,8071,1361,2002,3782,3781,6581,6631,4491,5141,5141,4741,4321,3591,4121,3711,3371,3371,4001,3071,4141,4141,3741,4801,2581,2581,2751,2591,1091,1091,2111,1611,3401,3401,0321,0149889881,1371,0931,0161,0169111,3631,2791,2798218541,1201,1201,1331,3611,8441,8441,7251,8371,8411,8371,8371,4201,6191,6192,1721,5226006003004005004002002000
   > Total Current Liabilities 
0
200
200
300
400
300
200
400
400
1,137
1,725
790
790
481
842
691
674
691
512
623
623
433
366
527
527
254
250
734
734
792
266
367
367
363
409
247
247
223
234
497
497
283
272
162
162
212
188
155
155
339
222
272
272
214
271
158
158
134
132
76
114
119
133
133
69
231
187
1,392
1,392
1,200
1,136
1,807
412
1,137
1,707
2,250
2,063
2,783
3,501
2,997
3,568
5,306
4,987
4,474
4,449
4,036
5,249
6,223
6,183
6,787
7,453
7,842
5,470
7,763
6,467
7,512
6,128
8,162
6,659
10,118
7,070
6,969
7,364
9,317
7,511
6,945
8,214
10,725
9,568
66,557
68,125
53,716
37,786
12,034
16,131
13,413
18,258
18,25813,41316,13112,03437,78653,71668,12566,5579,56810,7258,2146,9457,5119,3177,3646,9697,07010,1186,6598,1626,1287,5126,4677,7635,4707,8427,4536,7876,1836,2235,2494,0364,4494,4744,9875,3063,5682,9973,5012,7832,0632,2501,7071,1374121,8071,1361,2001,3921,39218723169133133119114761321341581582712142722722223391551551882121621622722834974972342232472474093633673672667927347342502545275273664336236235126916746918424817907901,7251,1374004002003004003002002000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
84
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31
0
0
0
0
0
0
47
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
143
145
146
147
124
87
50
13
0
0
0
0
0
0
0
0
99,162
115,499
0
0
244
200
421
450
453
2,576
993
1,050
1,678
2,064
997
749
857
1,769
1,807
58,355
58,590
2,842
2,157
2,286
2,351
1,208
922
9221,2082,3512,2862,1572,84258,59058,3551,8071,7698577499972,0641,6781,0509932,57645345042120024400115,49999,1620000000013508712414714614514300000000000000000000000000000000000004700000031000000000000000084000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
160
0
0
0
13
0
0
0
0
0
0
0
0
99,162
115,499
0
0
244
0
0
0
0
2,129
511
553
1,127
1,452
352
80
82
84
80
56,413
56,595
726
726
726
726
0
0
0072672672672656,59556,413808482803521,4521,1275535112,129000024400115,49999,162000000001300016000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
100
100
100
100
100
100
185
196
402
402
150
202
223
233
223
210
184
184
216
177
153
153
101
105
88
88
146
104
177
177
160
191
97
97
75
109
153
153
171
147
72
72
94
69
65
65
124
78
134
134
98
126
39
39
65
60
32
64
76
95
34
35
101
50
63
63
300
29
322
7
540
718
1,302
1,102
2,129
2,364
1,741
1,552
2,623
2,673
1,789
2,400
992
1,263
1,534
1,369
2,080
2,758
2,355
1,559
1,322
2,505
1,819
2,281
2,351
3,401
2,702
2,372
1,290
1,917
1,877
2,330
1,983
2,717
2,221
2,819
4,501
3,524
4,033
4,812
4,796
5,108
3,759
4,714
4,7143,7595,1084,7964,8124,0333,5244,5012,8192,2212,7171,9832,3301,8771,9171,2902,3722,7023,4012,3512,2811,8192,5051,3221,5592,3552,7582,0801,3691,5341,2639922,4001,7892,6732,6231,5521,7412,3642,1291,1021,3027185407322293006363501013534957664326065393912698134134781246565699472721471711531531097597971911601771771041468888105101153153177216184184210223233223202150402402196185100100100100100100000
       Other Current Liabilities 
0
200
200
200
300
200
100
300
300
951
1,529
388
388
62
72
61
60
61
48
439
130
36
32
374
220
29
21
479
479
450
30
39
39
40
32
90
43
84
60
344
279
40
53
31
31
47
54
32
32
26
17
26
26
18
27
26
26
26
30
23
34
27
38
35
25
33
44
1,243
1,243
948
1,037
912
321
515
768
727
741
494
1,000
1,156
1,953
2,543
2,256
2,642
2,005
3,009
2,944
3,611
3,733
3,636
4,578
5,302
3,709
6,224
3,427
5,238
3,176
5,090
2,619
4,608
3,367
4,253
3,412
5,094
3,715
3,762
4,242
6,400
4,418
3,154
5,543
46,363
30,221
3,407
7,400
7,655
11,951
11,9517,6557,4003,40730,22146,3635,5433,1544,4186,4004,2423,7623,7155,0943,4124,2533,3674,6082,6195,0903,1765,2383,4276,2243,7095,3024,5783,6363,7333,6112,9443,0092,0052,6422,2562,5431,9531,1561,0004947417277685153219121,0379481,2431,2434433253538273423302626262718262617263232544731315340279344608443903240393930450479479212922037432361304394861606172623883881,5299513003001002003002002002000
   > Long-term Liabilities 
0
0
0
100
100
100
100
200
200
385
447
829
829
939
996
1,146
1,167
1,146
1,213
1,221
1,221
928
766
593
593
599
571
545
545
571
644
649
649
730
729
741
741
790
798
0
843
878
939
946
946
1,047
1,087
1,103
1,103
1,141
1,152
1,142
1,142
1,093
1,128
1,179
1,179
1,237
1,280
1,284
1,318
1,355
1,381
1,381
1,380
1,432
1,471
986
986
986
99
895
527
777
901
850
813
1,027
1,014
1,000
1,000
1,000
1,000
1,000
1,000
1,000
22
2,612
2,450
21
99,187
115,525
117,780
120,127
122,750
125,127
130,930
133,641
136,276
141,687
146,817
149,268
151,668
154,422
113,397
111,173
118,919
109,965
76,076
20,722
21,602
34,825
36,571
39,220
40,371
44,341
62,538
62,53844,34140,37139,22036,57134,82521,60220,72276,076109,965118,919111,173113,397154,422151,668149,268146,817141,687136,276133,641130,930125,127122,750120,127117,780115,52599,187212,4502,612221,0001,0001,0001,0001,0001,0001,0001,0141,027813850901777527895999869869861,4711,4321,3801,3811,3811,3551,3181,2841,2801,2371,1791,1791,1281,0931,1421,1421,1521,1411,1031,1031,0871,04794694693987884307987907417417297306496496445715455455715995935937669281,2211,2211,2131,1461,1671,146996939829829447385200200100100100100000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124
87
50
13
0
0
0
0
0
0
0
0
0
0
0
0
99,162
115,499
117,754
120,074
122,461
124,917
127,444
130,043
132,717
138,131
143,327
145,870
148,315
151,095
110,150
107,984
0
105,828
56,325
49,624
0
32,289
0
0
0
0
0
0000032,289049,62456,325105,8280107,984110,150151,095148,315145,870143,327138,131132,717130,043127,444124,917122,461120,074117,754115,49999,16200000000000013508712400000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
849
748
811
785
718
161
587
550
593
564
520
530
530
597
649
683
729
729
741
761
790
798
843
859
878
939
947
1,012
1,048
1,086
1,103
1,158
1,141
1,152
1,142
1,112
1,093
1,128
1,179
1,209
1,236
1,280
1,283
1,318
1,355
1,381
1,380
1,396
1,432
1,471
986
986
0
0
0
527
776
777
763
763
1,014
1,014
1,000
1,000
1,000
1,000
1,000
1,000
1,000
22
0
0
21
25
26
26
53
46
35
28
19
93
190
259
335
453
580
678
808
805
757
979
1,537
0
1,097
2,158
0
0
0
0
00002,1581,09701,5379797578058086785804533352591909319283546532626252100221,0001,0001,0001,0001,0001,0001,0001,0141,0147637637777765270009869861,4711,4321,3961,3801,3811,3551,3181,2831,2801,2361,2091,1791,1281,0931,1121,1421,1521,1411,1581,1031,0861,0481,01294793987885984379879076174172972968364959753053052056459355058716171878581174884900000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
1,000
22
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000221,0001,0001,00000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
1,000
1,400
1,900
2,200
8,500
8,900
9,200
9,200
11,520
12,678
12,356
12,356
12,400
12,263
12,236
12,049
12,236
11,401
11,262
11,262
10,712
10,361
9,612
9,611
11,453
13,226
13,745
13,745
13,337
13,219
12,729
12,729
11,932
11,554
11,737
11,737
10,912
10,349
9,668
9,668
8,128
7,353
6,739
6,739
5,765
5,296
4,880
4,880
4,091
4,549
4,413
4,413
4,161
3,983
3,894
3,894
3,119
3,094
4,910
4,986
4,963
4,845
4,815
4,815
4,350
4,021
14,836
14,836
12,068
30,093
27,524
44,994
41,517
38,809
78,704
72,277
65,991
58,822
49,350
40,187
133,018
119,661
105,041
91,183
77,816
69,133
142,034
129,924
118,704
106,475
94,886
77,406
57,375
42,968
26,005
10,220
-7,379
-22,942
-36,990
-49,668
-62,812
-66,364
-69,750
-39,747
-35,071
-56,776
-61,964
-9,797
-22,264
-38,725
-38,663
-35,033
-19,888
-25,780
-34,887
-48,481
-48,481-34,887-25,780-19,888-35,033-38,663-38,725-22,264-9,797-61,964-56,776-35,071-39,747-69,750-66,364-62,812-49,668-36,990-22,942-7,37910,22026,00542,96857,37577,40694,886106,475118,704129,924142,03469,13377,81691,183105,041119,661133,01840,18749,35058,82265,99172,27778,70438,80941,51744,99427,52430,09312,06814,83614,8364,0214,3504,8154,8154,8454,9634,9864,9103,0943,1193,8943,8943,9834,1614,4134,4134,5494,0914,8804,8805,2965,7656,7396,7397,3538,1289,6689,66810,34910,91211,73711,73711,55411,93212,72912,72913,21913,33713,74513,74513,22611,4539,6119,61210,36110,71211,26211,26211,40112,23612,04912,23612,26312,40012,35612,35612,67811,5209,2009,2008,9008,5002,2001,9001,4001,0000
   Common Stock
0
0
0
0
0
0
0
0
8,219
8,579
8,579
8,543
8,543
8,438
8,388
8,353
8,305
8,353
8,305
8,302
8,302
8,200
8,198
8,199
8,198
10,429
12,353
12,342
12,342
12,342
12,378
12,488
12,488
12,582
12,863
12,863
12,863
12,863
12,863
12,863
12,863
12,878
12,878
12,878
12,878
9,971
12,878
12,878
12,878
12,878
13,678
13,804
13,804
13,804
13,804
13,804
13,970
13,804
14,139
14,139
14,139
14,139
14,139
14,333
14,333
14,333
14,333
22,986
22,986
25
39
39
41
42
42
45
45
45
45
45
45
51
51
51
51
52
52
55
55
56
54
54
54
54
54
55
55
55
55
56
57
58
60
61
65
68
69
80
97
97
100
14
14
14
21
24
0
02421141414100979780696865616058575655555555545454545456555552525151515145454545454542424139392522,98622,98614,33314,33314,33314,33314,13914,13914,13914,13914,13913,80413,97013,80413,80413,80413,80413,80413,67812,87812,87812,87812,8789,97112,87812,87812,87812,87812,86312,86312,86312,86312,86312,86312,86312,58212,48812,48812,37812,34212,34212,34212,35310,4298,1988,1998,1988,2008,3028,3028,3058,3538,3058,3538,3888,4388,5438,5438,5798,5798,21900000000
   Retained Earnings Total Equity00000-656,769-624,034-592,630-592,439-576,7340-570,668-547,865-538,879-517,205-492,966-474,054-455,297-436,067-414,653-393,318-372,884-352,069-330,348-308,156-286,058-262,833-241,972-225,676-208,601-192,144-177,289-161,154-143,855-125,989-110,915-97,752-86,566-74,314-65,41700000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-200
-200
-200
-200
-200
-200
-100
-274
-274
-274
-162
-274
-274
-274
-240
-259
-278
-292
-309
-309
-309
-274
-28
-28
-274
-28
-49
375
375
375
375
375
281
-111
-102
-102
-102
-102
-172
-274
-172
-274
-274
-274
-274
-274
-274
-274
-274
-274
-274
-274
-303
0
-326
0
0
0
-337
-337
0
0
-339
-339
0
0
-337
-274
0
0
0
11
22
26
28
11
7
12
3
1
-12
-9
69
-9
-204
-137
3
87
-6,584
59
-134
-159
-149
-104
44
-59
-58
150
140
94
91
-9
13
-17
-60
-232
-432
-245
-400
-631
-653
-360
-612
-618
-449
-1,057
-1,057-449-618-612-360-653-631-400-245-432-232-60-1713-99194140150-58-5944-104-149-159-13459-6,584873-137-204-969-9-12131271128262211000-274-33700-339-33900-337-337000-3260-303-274-274-274-274-274-274-274-274-274-274-274-172-274-172-102-102-102-102-111281375375375375375-49-28-274-28-28-274-309-309-309-292-278-259-240-274-274-274-162-274-274-274-100-200-200-200-200-200-2000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,519
1,535
1,594
7,925
8,093
0
51,805
53,013
74,266
75,937
78,427
126,469
128,873
131,356
133,079
135,868
137,893
243,894
245,608
248,776
252,295
255,257
261,362
350,577
355,458
360,620
414,262
426,091
430,734
432,885
440,154
443,857
448,609
452,344
457,987
463,178
469,302
475,072
495,857
514,122
553,134
580,652
0
560,185
627,853
627,853
630,903
663,812
0
0
0
0
0
00000663,812630,903627,853627,853560,1850580,652553,134514,122495,857475,072469,302463,178457,987452,344448,609443,857440,154432,885430,734426,091414,262360,620355,458350,577261,362255,257252,295248,776245,608243,894137,893135,868133,079131,356128,873126,46978,42775,93774,26653,01351,80508,0937,9251,5941,5351,5190000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000-45,0670-45,0670-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067000000000000000000000-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-273-274-274-274-274-274-274-274-274-274-274-273-274-273-274-273-274-274-274-274-274-274-274-27400000000000000000
   Other Stockholders Equity 
0
2,000
2,000
2,000
2,000
8,300
8,300
8,400
8,300
315
315
204
315
315
315
281
300
41
41
0
41
41
315
0
41
315
41
481
56
75
94
271
271
268
226
290
187
187
187
0
484
212
13,379
13,448
13,448
3,499
13,477
13,513
13,513
13,551
703
14,726
14,726
775
806
14,975
14,649
864
865
15,022
15,031
895
902
0
973
1,262
1,321
7,651
7,651
31,244
51,805
53,013
74,266
75,937
78,427
126,469
128,873
131,356
133,079
135,868
137,893
243,894
245,608
248,776
252,295
255,257
261,362
350,577
355,458
360,620
369,195
381,024
385,667
387,818
395,087
398,790
403,542
407,277
412,920
418,111
424,235
430,005
450,790
469,055
508,067
535,585
502,314
515,118
582,786
585,274
585,836
611,990
621,172
649,567
657,904
660,213
661,889
661,889660,213657,904649,567621,172611,990585,836585,274582,786515,118502,314535,585508,067469,055450,790430,005424,235418,111412,920407,277403,542398,790395,087387,818385,667381,024369,195360,620355,458350,577261,362255,257252,295248,776245,608243,894137,893135,868133,079131,356128,873126,46978,42775,93774,26653,01351,80531,2447,6517,6511,3211,262973090289515,03115,02286586414,64914,97580677514,72614,72670313,55113,51313,51313,4773,49913,44813,44813,3792124840187187187290226268271271947556481413154103154141041413002813153153152043153158,3008,4008,3008,3002,0002,0002,0002,0000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.